Page 6 - Nasdaq Cere News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cere. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cere Today - Breaking & Trending Today

Cerevel Therapeutics (NASDAQ:CERE) Hits New 52-Week Low at $20.48

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $20.48 and last traded at $20.68, with a volume of 441458 shares. The stock had previously closed at $20.80. Wall Street Analysts Forecast Growth CERE has been the […] ....

United States , N Anthony Coles , Pauld Burgess , Royal Bank , Morgan Stanley , Cerevel Therapeutics Holdings Inc , Securities Exchange Commission , Ameritas Investment Partners Inc , Centaurus Financial Inc , Tower Research Capital , Cerevel Therapeutics Holdings , Get Free Report , Cerevel Therapeutics , Directorn Anthony Coles , Exchange Commission , Forest Capital Management , Research Capital , Ameritas Investment Partners , Investment Partners , Therapeutics Holdings , Cerevel Therapeutics Daily , Nasdaq Cere ,

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Position Increased by Affinity Asset Advisors LLC

Affinity Asset Advisors LLC raised its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 76.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 380,000 shares of the biotechnology company’s stock after purchasing an additional 165,000 shares during the […] ....

United States , Pauld Burgess , Securities Exchange Commission , Voya Investment Management , Board Of Administration Florida Retirement System , Cerevel Therapeutics Holdings Inc , Affinity Asset Advisors , Royal Bank , Morgan Stanley , Cerevel Therapeutics Holdings , Free Report , Asset Advisors , Cerevel Therapeutics , Florida Retirement System , Investment Management , State Retirement System , Amalgamated Bank , Director Marijn , Exchange Commission , Therapeutics Holdings , Get Free Report , Cerevel Therapeutics Daily , Nasdaq Cere , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Profund Advisors LLC Takes $959,000 Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)

Profund Advisors LLC purchased a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 39,316 shares of the biotechnology company’s stock, valued at approximately $959,000. Other hedge funds and other institutional […] ....

United States , N Anthony Coles , Profund Advisors , Royal Bank , Cerevel Therapeutics Holdings Inc , Board Of Administration Florida Retirement System , Morgan Stanley , Wells Fargo Company , Cerevel Therapeutics Company Profile , Securities Exchange Commission , Voya Investment Management , Cerevel Therapeutics Holdings , Free Report , Florida Retirement System , Cerevel Therapeutics , Investment Management , State Retirement System , Amalgamated Bank , Wells Fargo , Director Marijn , Directorn Anthony Coles , Therapeutics Holdings , Get Free Report , Visit Holdingschannel , Cerevel Therapeutics Daily , Nasdaq Cere ,

Mizuho Trims Cerevel Therapeutics (NASDAQ:CERE) Target Price to $25.00

Cerevel Therapeutics (NASDAQ:CERE – Free Report) had its price target decreased by Mizuho from $29.00 to $25.00 in a research report released on Monday, MarketBeat reports. Mizuho currently has a neutral rating on the biotechnology company’s stock. A number of other research analysts have also weighed in on the stock. Bank of America lowered shares […] ....

United States , Mark Bodenrader , Cerevel Therapeutics Company Profile , Wells Fargo Company , Morgan Stanley , Barclays Plc , Boone Capital Management , Vanguard Group Inc , Cerevel Therapeutics Holdings Inc , Cerevel Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Marijn , Street Corp , Therapeutics Holdings , Cerevel Therapeutics Daily , Nasdaq Cere , Lower Price Target ,

Cerevel Therapeutics (NASDAQ:CERE) Reaches New 1-Year Low on Analyst Downgrade

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) hit a new 52-week low on Friday after Morgan Stanley lowered their price target on the stock from $46.00 to $42.00. Morgan Stanley currently has an overweight rating on the stock. Cerevel Therapeutics traded as low as $22.58 and last traded at $22.75, with a volume […] ....

United States , Sakhalinskaya Oblast , Ceon Anthony Coles , Geode Capital Management , Pricet Rowe Associates Inc , Wells Fargo Company , Cerevel Therapeutics Holdings Inc , Blackrock Inc , Morgan Stanley , Securities Exchange Commission , Vanguard Group Inc , Cerevel Therapeutics Holdings , Get Free Report , Cerevel Therapeutics , Anthony Coles , Exchange Commission , Director Marijn , Street Corp , Capital Management , Therapeutics Holdings , Cerevel Therapeutics Daily , Nasdaq Cere ,